CHD4 and triple-negative breast carcinoma: In addition, recent studies suggested that CHD4 has a potential to be a prognostic biomarker in triple-negative breast cancer 26, 35 and high CHD4 and 8-hydroxy-deoxyguanosine levels as well as low expression of TSGs were strongly correlated with early disease recurrence and decreased overall survival in CRC patients 21.